X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with SHASUN PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs SHASUN PHARMA - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. SHASUN PHARMA WOCKHARDT LTD./
SHASUN PHARMA
 
P/E (TTM) x 16.7 123.9 13.5% View Chart
P/BV x 1.7 8.5 19.9% View Chart
Dividend Yield % 0.0 0.2 -  

Financials

 WOCKHARDT LTD.   SHASUN PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
SHASUN PHARMA
Mar-14
WOCKHARDT LTD./
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,00094 2,123.1%   
Low Rs70646 1,547.8%   
Sales per share (Unadj.) Rs403.7214.2 188.5%  
Earnings per share (Unadj.) Rs29.55.3 552.3%  
Cash flow per share (Unadj.) Rs42.415.8 267.8%  
Dividends per share (Unadj.) Rs01.00 0.0%  
Dividend yield (eoy) %01.4 0.0%  
Book value per share (Unadj.) Rs323.453.3 606.3%  
Shares outstanding (eoy) m110.5156.62 195.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 1,026.8%   
Avg P/E ratio x45.913.1 350.5%  
P/CF ratio (eoy) x31.94.4 722.7%  
Price / Book Value ratio x4.21.3 319.2%  
Dividend payout %018.7 0.0%   
Avg Mkt Cap Rs m149,5093,958 3,777.6%   
No. of employees `0007.4NA-   
Total wages/salary Rs m9,4432,164 436.5%   
Avg. sales/employee Rs Th6,048.6NM-  
Avg. wages/employee Rs Th1,280.2NM-  
Avg. net profit/employee Rs Th441.5NM-  
INCOME DATA
Net Sales Rs m44,61412,127 367.9%  
Other income Rs m970229 422.7%   
Total revenues Rs m45,58412,356 368.9%   
Gross profit Rs m5,0381,009 499.3%  
Depreciation Rs m1,426594 240.2%   
Interest Rs m1,012415 243.8%   
Profit before tax Rs m3,570230 1,554.2%   
Minority Interest Rs m-650-   
Prior Period Items Rs m60 -2,133.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255-73 -350.4%   
Profit after tax Rs m3,257302 1,077.9%  
Gross profit margin %11.38.3 135.7%  
Effective tax rate %7.1-31.7 -22.5%   
Net profit margin %7.32.5 293.0%  
BALANCE SHEET DATA
Current assets Rs m39,9066,884 579.7%   
Current liabilities Rs m18,4238,456 217.9%   
Net working cap to sales %48.2-13.0 -371.5%  
Current ratio x2.20.8 266.1%  
Inventory Days Days9062 146.3%  
Debtors Days Days98108 91.3%  
Net fixed assets Rs m35,8324,970 720.9%   
Share capital Rs m553113 487.6%   
"Free" reserves Rs m30,3702,875 1,056.4%   
Net worth Rs m35,7393,020 1,183.3%   
Long term debt Rs m16,5421,817 910.2%   
Total assets Rs m79,52213,347 595.8%  
Interest coverage x4.51.6 291.5%   
Debt to equity ratio x0.50.6 76.9%  
Sales to assets ratio x0.60.9 61.7%   
Return on assets %5.45.4 99.9%  
Return on equity %9.110.0 91.1%  
Return on capital %8.713.3 64.9%  
Exports to sales %11.646.4 25.0%   
Imports to sales %4.514.2 31.3%   
Exports (fob) Rs m5,1775,622 92.1%   
Imports (cif) Rs m1,9901,728 115.2%   
Fx inflow Rs m7,5895,843 129.9%   
Fx outflow Rs m2,8782,173 132.5%   
Net fx Rs m4,7113,669 128.4%   
CASH FLOW
From Operations Rs m716398 180.1%  
From Investments Rs m-8,182-1,635 500.4%  
From Financial Activity Rs m2,5431,309 194.3%  
Net Cashflow Rs m-4,92371 -6,914.6%  

Share Holding

Indian Promoters % 74.5 39.2 190.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 3.6 63.9%  
FIIs % 7.7 17.6 43.8%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 39.6 38.9%  
Shareholders   67,757 20,750 326.5%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   SUVEN LIFE  SUN PHARMA  PFIZER  FDC LTD.  ORCHID PHARMA LTD  

Compare WOCKHARDT LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 18, 2017 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - AUROBINDO PHARMA COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS